|
Volumn 44, Issue 4, 2012, Pages 907-909
|
Clinical experience of tacrolimus with everolimus in heart transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CORTICOSTEROID;
CREATININE;
EVEROLIMUS;
PANEL REACTIVE ANTIBODY;
TACROLIMUS;
ADULT;
AGED;
AORTA BALLOON;
CARDIAC GRAFT REJECTION;
CLINICAL ARTICLE;
COLD ISCHEMIA;
CONFERENCE PAPER;
CONTROLLED STUDY;
CORONARY ARTERY BYPASS GRAFT;
CREATININE BLOOD LEVEL;
DIABETES MELLITUS;
DRUG EFFICACY;
DRUG SAFETY;
ECHOCARDIOGRAPHY;
EXTRACORPOREAL OXYGENATION;
FEMALE;
HEART HEMODYNAMICS;
HEART MUSCLE BIOPSY;
HEART TRANSPLANTATION;
HUMAN;
HYPERLIPIDEMIA;
HYPERTENSION;
IMMUNE DEFICIENCY;
KIDNEY FUNCTION;
LIVING DONOR;
MALE;
POST TREATMENT SURVIVAL;
PRIORITY JOURNAL;
RESUSCITATION;
SEPTICEMIA;
SURGICAL MORTALITY;
ADOLESCENT;
ADULT;
AGED;
CHILD;
DIABETES MELLITUS;
DRUG THERAPY, COMBINATION;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEART TRANSPLANTATION;
HUMANS;
HYPERLIPIDEMIAS;
HYPERTENSION;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
SIROLIMUS;
SURVIVAL ANALYSIS;
TACROLIMUS;
TAIWAN;
TIME FACTORS;
TREATMENT OUTCOME;
YOUNG ADULT;
|
EID: 84860748127
PISSN: 00411345
EISSN: 18732623
Source Type: Journal
DOI: 10.1016/j.transproceed.2012.01.094 Document Type: Conference Paper |
Times cited : (19)
|
References (9)
|